[Ecological viewpoints in antibacterial chemotherapy].
D000151:Acinetobacter Infections / Q000188:drug therapy; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use; D003015:Clostridium Infections; D003352:Corynebacterium; D004357:Drug Synergism; D004751:Enteritis / Q000188:drug therapy; D004917:Erythromycin / Q000627:therapeutic use; D004927:Escherichia coli Infections / Q000188:drug therapy; D005260:Female; D006801:Humans; D007239:Infections / Q000188:drug therapy*; D009164:Mycobacterium Infections / Q000188:drug therapy; D009181:Mycoses / Q000188:drug therapy; D009355:Neomycin / Q000627:therapeutic use; D010406:Penicillins / Q000627:therapeutic use; D012141:Respiratory Tract Infections / Q000188:drug therapy; D013203:Staphylococcal Infections / Q000188:drug therapy; D013290:Streptococcal Infections / Q000188:drug therapy; D013307:Streptomycin / Q000627:therapeutic use; D013752:Tetracycline / Q000627:therapeutic use; D014627:Vaginitis / Q000188:drug therapy
D000900:Anti-Bacterial Agents; D000935:Antifungal Agents; D010406:Penicillins; D004917:Erythromycin; D013752:Tetracycline; D009355:Neomycin; D013307:Streptomycin
Okologische Gesichtspunkte in der antibakteriellen Chemotherapie.